Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04056403
Other study ID # 201907006RINC
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 2019
Est. completion date May 2021

Study information

Verified date August 2019
Source National Taiwan University Hospital
Contact Chun-Yu Wu
Phone 0972653376
Email longersolo@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To compare the labor epidural analgesic (EA) profiles between landmark insertion EA levels which are congruent and ingruent to ultrasound confirmation in lateral decubitus position.


Description:

Epidural analgesia is the mainstream method for labor analgesia. Landmark identification of L3 to L5 spinous process is most commonly applied for determination of epidural insertion. However, the precision of epidural catheter insertion site was affected by physiological and anatomical variations in pregnant women and positions such as sitting or lateral decubitus. Previous study showed the clinical estimation would be ≥ 1 vertebral level higher than the anatomical position determined by ultrasound at least 40% of the time in sitting position among western pregnant women. For asian parturients, epidural analgesia is commonly performed in lateral decubitus position because of smaller stature. In addition, it remains uncertain whether the landmark epidural insertion level congruent or ingruent is associated with different analgesia profiles such as the dosage requirement and the frequncy of adjustment.


Recruitment information / eligibility

Status Recruiting
Enrollment 250
Est. completion date May 2021
Est. primary completion date May 2021
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 55 Years
Eligibility Inclusion:

1. Normal spontaneous delivery parturients receiving labor epidural analgesia in first stage of labor

2. Using patient-controlled epidural analgesia

Exclusion:

1. who has an accidental epidural puncture

2. who receives epidural insertion by ultrasound identification

3. who uses of magnesium sulfate

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of landmark epidural level Validation of landmark localization of epidural insertion level by using ultrasound examination 10 minute
Secondary Labor analgesic dose Influences of accurate epidural insertion level on labor epidural analgesic dose one day
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04441463 - Simultaneous Study of the Serum Tryptase Level of the Mother and the Child During Childbirth (TryPla) N/A
Not yet recruiting NCT01943565 - Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study Phase 4
Terminated NCT03222414 - Non-invasive Versus Invasive Blood Pressure Measurement in the Morbidly Obese Parturient With Severe Preeclampsia N/A